Deutsche Bank Ag\ Lineage Cell Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Lineage Cell Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 59,030 shares of LCTX stock, worth $34,827. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,030

Previous 57,611 2.46%

Holding current value

$34,827

Previous $57,000 7.02%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$0.8 - $1.12 $1,135 - $1,589	1,419 Added 2.46%	59,030 $53,000
Q2 2024 Aug 14, 2024	SELL	$0.89 - $1.47 $15,386 - $25,413	-17,288 Reduced 23.08%	57,611 $57,000
Q1 2024 May 15, 2024	SELL	$0.86 - $1.48 $1,286 - $2,214	-1,496 Reduced 1.96%	74,899 $110,000
Q4 2023 Feb 14, 2024	SELL	$0.91 - $1.35 $2,456 - $3,643	-2,699 Reduced 3.41%	76,395 $83,000
Q3 2023 Nov 09, 2023	BUY	$1.16 - $1.53 $79,050 - $104,264	68,147 Added 622.52%	79,094 $93,000
Q2 2023 Aug 14, 2023	BUY	$1.26 - $1.53 $13,793 - $16,748	10,947 New	10,947 $15,000
Q2 2022 Aug 11, 2022	SELL	$1.12 - $1.61 $76,255 - $109,616	-68,085 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.21 - $2.48 $9,771 - $20,028	-8,076 Reduced 10.6%	68,085 $105,000
Q4 2021 Feb 11, 2022	BUY	$1.84 - $2.68 $7,407 - $10,789	4,026 Added 5.58%	76,161 $187,000
Q3 2021 Nov 04, 2021	BUY	$2.26 - $2.86 $323 - $408	143 Added 0.2%	72,135 $182,000
Q2 2021 Aug 11, 2021	BUY	$2.17 - $3.0 $156,222 - $215,976	71,992 New	71,992 $205,000
Q2 2020 Aug 13, 2020	SELL	$0.71 - $1.18 $23,912 - $39,742	-33,680 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$0.6 - $1.58 $1,312 - $3,457	-2,188 Reduced 6.1%	33,680 $28,000
Q4 2019 Feb 14, 2020	BUY	$0.54 - $1.01 $3,997 - $7,476	7,402 Added 26.0%	35,868 $31,000
Q3 2019 Nov 14, 2019	BUY	$0.85 - $1.24 $24,196 - $35,297	28,466 New	28,466 $27,000

Others Institutions Holding LCTX

# of Institutions

120

Shares Held

94.2M

Call Options Held

63.8K

Put Options Held

View Full List

About Lineage Cell Therapeutics, Inc.

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $100M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

More about LCTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account